Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 5/20 | 0.58 |
| ▸ | CYP1B1 | Q16678 | 5/20 | 0.58 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.58 |
| ▸ | TTR | P02766 | 2/20 | 0.58 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.58 |
| ▸ | BACE1 | P56817 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.56 |
| ▸ | MEN1 | O00255 | 3/20 | 0.56 |
| ▸ | MAPT | P10636 | 3/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.56 |
| ▸ | HPGD | P15428 | 2/20 | 0.56 |
| ▸ | USP2 | O75604 | 1/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | ERN1 | O75460 | 2/20 | 0.53 |
| ▸ | ABL1 | P00519 | 3/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29958196 | 1.00 | CYP1A1 (0.58) | CYP1A1CYP1B1PTGS2TTRALOX5 | |
| SCHEMBL228003 | 0.86 | CYP1A1 (0.64) | CYP1A1CYP1B1PTGS2TTRALOX5 | |
| SCHEMBL1663786 | 0.86 | ALDH1A1 (0.58) | CYP1A1CYP1B1PTGS2TTRALOX5 | |
| Water SCHEMBL28227114 | 0.84 | CYP1A1 (0.61) | CYP1A1CYP1B1PTGS2TTRALOX5 | |
| Formic Acid Methyl Ester SCHEMBL28071788 | 0.80 | CYP1A1 (0.56) | CYP1A1CYP1B1PTGS2TTRALOX5 | |
| SCHEMBL19359679 | 0.80 | CYP1A1 (0.77) | CYP1A1CYP1B1PTGS2TTRALOX5 | |
| SCHEMBL11931426 | 0.80 | NPC1 (0.69) | CYP1A1ALDH1A1MAPTSMN1; SMN2NPC1 | |
| SCHEMBL26908513 | 0.79 | BACE1 (0.42) | CYP1A1CYP1B1PTGS2TTRALOX5 | |
| SCHEMBL9928608 | 0.78 | CYP1A1 (0.58) | CYP1A1CYP1B1PTGS2TTRALOX5 | |
| SCHEMBL29951799 | 0.78 | ALDH1A1 (0.50) | CYP1A1CYP1B1PTGS2TTRALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 232 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260002924-A1 | METHOD FOR SELECTING ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS FROM MIXTURE OF ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS AND OTHER TYPES OF POLYMERS | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2026-01-01 | — | — | US | claimed |
| US-20250049831-A1 | ANTIVIRAL USE OF BISEPOXYLIGNAN COMPOUND, AND BISEPOXYLIGNAN COMPOSITION AND PREPARATION OF BISEPOXYLIGNAN COMPOUND | GE, XIN (CN) | 2025-02-13 | — | — | US | claimed |
| EP-4477693-A1 | METHOD FOR SELECTING ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS FROM MIXTURE OF ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS AND OTHER TYPES OF POLYMERS | Korea Research Institute of Chemical Technology (KR) | 2024-12-18 | — | — | EP | claimed |
| EP-4442262-A1 | ANTIVIRAL USE OF BISEPOXYLIGNAN COMPOUND, AND BISEPOXYLIGNAN COMPOSITION AND PREPARATION OF BISEPOXYLIGNAN COMPOUND | Ge, Xin (CN) | 2024-10-09 | — | — | EP | claimed |
| WO-2023195794-A1 | METHOD FOR SELECTING ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS FROM MIXTURE OF ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS AND OTHER TYPES OF POLYMERS | 한국화학연구원 | 2023-10-12 | — | — | WO | claimed |
| WO-2023098650-A1 | ANTIVIRAL USE OF BISEPOXYLIGNAN COMPOUND, AND BISEPOXYLIGNAN COMPOSITION AND PREPARATION OF BISEPOXYLIGNAN COMPOUND | 盖鑫 | 2023-06-08 | — | — | WO | claimed |
| CN-116196321-A | Application and preparation of bisepoxylignanoid compound and antiviral composition | 盖鑫 | 2023-06-02 | — | — | CN | claimed |
| US-20230148641-A1 | FLAVOR COMPOSITION | FIRMENICH SA (CH) | 2023-05-18 | — | — | US | claimed |
| EP-4125427-A1 | FLAVOR COMPOSITION | Firmenich SA (CH) | 2023-02-08 | — | — | EP | claimed |
| CN-115279206-A | Flavor composition | 弗门尼舍有限公司 | 2022-11-01 | — | — | CN | claimed |
| WO-2021198199-A1 | FLAVOR COMPOSITION | FIRMENICH SA (CH) | 2021-10-07 | — | — | WO | claimed |
| US-10751330-B2 | Human therapeutic agents | ANKH LIFE SCIENCES LIMITED (IE) | 2020-08-25 | — | — | US | claimed |
| US-20200147061-A1 | HUMAN THERAPEUTIC AGENTS | ANKH LIFE SCIENCES LIMITED (IE) | 2020-05-14 | — | — | US | claimed |
| US-10092550-B2 | Therapeutic compositions containing curcumin, harmine, and isovanillin components, and methods of use thereof | IONS PHARMACEUTICAL S.À R.L. (LU) | 2018-10-09 | — | — | US | claimed |
| US-20170105975-A1 | THERAPEUTIC COMPOSITIONS CONTAINING HARMINE AND ISOVANILLIN COMPONENTS, AND METHODS OF USE THEREOF | IONS PHARMACEUTICAL S.À R.L. (LU) | 2017-04-20 | — | — | US | claimed |
| US-20170042865-A1 | THERAPEUTIC COMPOSITIONS CONTAINING CURCUMIN, HARMINE, AND ISOVANILLIN COMPONENTS, AND METHODS OF USE THEREOF | IONS PHARMACEUTICAL S.À R.L. (LU) | 2017-02-16 | — | — | US | claimed |
| EP-4737508-A1 | CHEMICAL RECYCLING METHOD FOR MIXED WASTE POLYMERS | Korea Research Institute of Chemical Technology (KR) | 2026-05-06 | — | — | EP | disclosed |
| US-20260002924-A1 | METHOD FOR SELECTING ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS FROM MIXTURE OF ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS AND OTHER TYPES OF POLYMERS | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2026-01-01 | — | — | US | disclosed |
| US-4133729-A | Production of 1,2-bis(hydroxy-phenyl)ethane-1,2-diols by electrolytic reduction | MONSANTO COMPANY (US) | 1979-01-09 | — | — | US | disclosed |
| US-4087336-A | Electrolytic reductive coupling of hydroxybenzaldehydes | MONSANTO COMPANY (US) | 1978-05-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260002924-A1 | METHOD FOR SELECTING ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS FROM MIXTURE OF ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS AND OTHER TYPES OF POLYMERS | FGB, NR4A1, CYP2E1 | CYP1A1 35/4885CYP1B1 19/4885PTGS2 782/4885 |
| US-10751330-B2 | Human therapeutic agents | INMT, HNMT, HASPIN | CYP1A1 2202/4885CYP1B1 3037/4885PTGS2 2234/4885 |
| US-20170042865-A1 | THERAPEUTIC COMPOSITIONS CONTAINING CURCUMIN, HARMINE, AND ISOVANILLIN COMPONENTS, AND METHODS OF USE THEREOF | INMT, HNMT, CPT1A | CYP1A1 1680/4885CYP1B1 1687/4885PTGS2 2108/4885 |
| US-20250049831-A1 | ANTIVIRAL USE OF BISEPOXYLIGNAN COMPOUND, AND BISEPOXYLIGNAN COMPOSITION AND PREPARATION OF BISEPOXYLIGNAN COMPOUND | ACE2, LBR, YWHAZ | CYP1A1 1012/4885CYP1B1 1371/4885PTGS2 621/4885 |
| US-10092550-B2 | Therapeutic compositions containing curcumin, harmine, and isovanillin components, and methods of use thereof | INMT, HNMT, CPT1A | CYP1A1 1680/4885CYP1B1 1687/4885PTGS2 2108/4885 |
| US-20170105975-A1 | THERAPEUTIC COMPOSITIONS CONTAINING HARMINE AND ISOVANILLIN COMPONENTS, AND METHODS OF USE THEREOF | INMT, HNMT, COMT | CYP1A1 1827/4885CYP1B1 1866/4885PTGS2 2709/4885 |
| US-20200147061-A1 | HUMAN THERAPEUTIC AGENTS | INMT, HNMT, HASPIN | CYP1A1 2202/4885CYP1B1 3037/4885PTGS2 2234/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.